
Daily cellular protocol
NAD+
500mg of NAD+ supported by Quercetin and Resveratrol, dosed once daily for cellular energy and metabolic health.
View NAD+The buyer checklist
We are not going to hand you a ranked list. We are going to hand you the four checks that would let you build your own.

This guide is part of our NAD+ supplement guides track. For continuity, read our oral NAD+ supplement and when to take NAD+.
The short answer
Oral is the route with the randomized evidence — the Martens crossover, the pooled NMN performance and metabolic reviews, all oral. Within that route, products differ far less by brand than by four checkable things: a named precursor, a milligram dose inside the studied range, lot-specific third-party testing, and claims that stop where the evidence stops. Independent assay work found only seven of 18 commercial NMN products within 10% of label, which tells you which check matters most.
Decision brief
Oral dosing is what the randomized human evidence in this field is built on.
Only 7 of 18 assayed commercial NMN products landed within 10% of their label claim.
A named precursor at a stated milligram amount is the minimum bar.
Overclaiming is the most reliable signal that a brand is not evidence-led.
Muscle Velocity standard
500mg of NAD+ with Quercetin and Resveratrol. Named compound, stated dose, and no claim we cannot point at a trial for.

Daily cellular protocol
500mg of NAD+ supported by Quercetin and Resveratrol, dosed once daily for cellular energy and metabolic health.
View NAD+Educational content only. Supplements are not a substitute for medical care. Speak with a qualified healthcare professional when a condition, medication, or persistent symptom is involved.
Every foundational trial in this field used oral dosing. Martens and colleagues gave 500mg of nicotinamide riboside twice daily in a double-blind placebo-controlled crossover and measured roughly a 60% rise in NAD+ within immune cells. The NMN trials pooled in 2024 reviews used oral doses from 150mg to 2000mg per day.
That matters because it means an oral protocol is the one you can actually map onto published research. You can pick a dose someone has studied and run it for a duration someone has studied.
It is also the route without appointments, cannulas, or a clinic's pricing model attached. For a compound you intend to take daily for months, friction is not a minor consideration.
First, a named precursor. Nicotinamide riboside, NMN, or nicotinamide. If none appears in the supplement facts panel, the front-label NAD+ branding is not backed by a compound with human trial evidence.
Second, a milligram dose inside the studied range. Third, verification. When Sandalova and colleagues assayed 18 commercial NMN products by HPLC-QqQ-MS for GeroScience, measured content ranged from nothing detectable to 11.2% above claim. Only seven were within 10% of label. Three had no detectable NMN at all.
Fourth, read the claims. Products promising reversed ageing, cured fatigue, or guaranteed outcomes are contradicted by their own field's meta-analyses. That is not a stylistic complaint — it tells you the company is not reading the literature it is selling into.
None of these checks makes a product work better than the evidence allows. A perfectly manufactured, third-party-verified NAD+ precursor at an ideal dose still faces the same outcome literature: metabolic markers null, strength and aerobic effects nonsignificant, NAD+ reliably raised.
So the checks protect you from buying something fake or underdosed. They do not protect you from the category's honest uncertainty, and no brand can sell you out of that.
Buy on that basis and the decision becomes simple. Pick a verified product at a studied dose, run it for eight to twelve weeks against one outcome you defined in advance, and let the result decide whether it stays in your routine.
Buying checklist
Nicotinamide riboside, NMN, or nicotinamide. Front-label NAD+ branding is not a compound.
150–2000mg/day covers the published trials. Outside it, you are improvising with no reference point.
The single highest-value check, given that 11 of 18 assayed products missed their label claim by more than 10%.
Raising NAD+ is defensible. Promising outcomes the meta-analyses found null is a disqualifier.
Fit check
Common questions
No evidence supports a single best product. What distinguishes oral NAD+ supplements is a named precursor at a stated dose inside the studied range, lot-specific third-party testing, and claims that stop at raising NAD+. Beyond that, compare price per gram.
For raising circulating NAD+, yes — that is well established, including a roughly 60% increase in immune-cell NAD+ in the Martens crossover trial. For downstream outcomes like metabolism and strength, pooled 2024 reviews found largely null or nonsignificant results.
Ask for a certificate of analysis matched to your lot number, not a generic supplier document for the raw ingredient. A 2024 GeroScience analysis of 18 commercial NMN products found only seven within 10% of label claim and three with none detectable.
Eight to twelve weeks at a consistent daily dose, judged against one outcome you defined before starting. That matches the four-to-twelve-week duration of the trials that measured anything. Shorter trials tell you very little.
Evidence desk
Continue the NAD+ guide
Dose, timing, and how to verify a label before you pay for it.
All NAD+ guides